Anbio Biotechnology (NASDAQ:NNNN) Sees Large Volume Increase – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN) shares saw unusually-high trading volume on Tuesday . Approximately 218,119 shares changed hands during trading, an increase of 233% from the previous session’s volume of 65,521 shares.The stock last traded at $6.4710 and had previously closed at $6.54.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Anbio Biotechnology currently has a consensus rating of “Sell”.

Anbio Biotechnology Trading Up 0.9%

The stock has a 50-day simple moving average of $9.50 and a 200 day simple moving average of $19.26.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.